Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$1.22B |
| 3 |
Progressive
PGR
|
+$1.12B |
| 4 |
Exelon
EXC
|
+$977M |
| 5 |
Pfizer
PFE
|
+$713M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.5B |
| 2 |
Boston Scientific
BSX
|
+$723M |
| 3 |
MDCO
Medicines Co
MDCO
|
+$709M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$590M |
| 5 |
Expedia Group
EXPE
|
+$558M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.74% |
| 2 | Financials | 15.42% |
| 3 | Technology | 14.93% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
| $219K | ﹤0.01% |
2,400
| – | – |
|
1902
iShares Core MSCI Europe ETF
IEUR
$8.97B
| $216K | ﹤0.01% |
+4,339
| New | +$207K |
|
|
CTXS
1903
DELISTED
Citrix Systems Inc
CTXS
| $215K | ﹤0.01% |
+1,934
| New | +$208K |
|
|
IMGN
1904
DELISTED
Immunogen Inc
IMGN
| $213K | ﹤0.01% |
+41,707
| New | +$142K |
|
1905
Sabre
SABR
$723M
| $209K | ﹤0.01% |
9,292
+257
| +3% | +$5.7K |
|
1906
Fox Class B
FOX
$21.8B
| $204K | ﹤0.01% |
5,615
-3,726
| -40% | -$125K |
|
|
CART
1907
DELISTED
Carolina Trust BancShares
CART
| $189K | ﹤0.01% |
14,491
-1,736
| -11% | -$20.3K |
|
|
TVRD
1908
Tvardi Therapeutics
TVRD
$19.8M
| $186K | ﹤0.01% |
320
-200
| -38% | -$140K |
|
1909
Amcor
AMCR
$20.8B
| $175K | ﹤0.01% |
3,237
| – | – |
|
1910
Opko Health
OPK
$993M
| $170K | ﹤0.01% |
115,533
-72,294
| -38% | -$121K |
|
|
NSCO.WS
1911
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
| $170K | ﹤0.01% |
363,082
+175,700
| +94% | +$97K |
|
|
YRD
1912
Yiren Digital
YRD
$95.4M
| $130K | ﹤0.01% |
+23,398
| New | +$137K |
|
|
VRAY
1913
DELISTED
ViewRay, Inc.
VRAY
| $124K | ﹤0.01% |
29,243
-18,309
| -39% | -$59.2K |
|
|
MRSN
1914
DELISTED
Mersana Therapeutics
MRSN
| $121K | ﹤0.01% |
841
-33,876
| -98% | -$2.48M |
|
|
UBFO
1915
DELISTED
United Security Bancshares
UBFO
| $120K | ﹤0.01% |
11,152
-1,529
| -12% | -$15.9K |
|
|
SYBX
1916
DELISTED
Synlogic
SYBX
| $115K | ﹤0.01% |
2,988
-202,637
| -99% | -$6.82M |
|
|
CLSD
1917
DELISTED
Clearside Biomedical
CLSD
| $114K | ﹤0.01% |
2,623
-1,634
| -38% | -$34.3K |
|
1918
Flotek Industries
FTK
$838M
| $101K | ﹤0.01% |
+8,416
| New | +$97.1K |
|
|
ADAP
1919
DELISTED
Adaptimmune Therapeutics
ADAP
| $100K | ﹤0.01% |
83,302
-1,513,299
| -95% | -$1.61M |
|
1920
BioCryst Pharmaceuticals
BCRX
$2.28B
| $78K | ﹤0.01% |
22,708
-5,420
| -19% | -$13.6K |
|
|
BMY.RT
1921
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $63K | ﹤0.01% |
+20,631
| New | +$53.6K |
|
1922
RPC Inc
RES
$1.23B
| $58K | ﹤0.01% |
11,180
-224,793
| -95% | -$1.01M |
|
1923
Cemex
CX
$17.1B
| $52K | ﹤0.01% |
13,747
-2,983,544
| -100% | -$11.4M |
|
1924
Veritone
VERI
$98.5M
| $27K | ﹤0.01% |
11,133
-3,924
| -26% | -$11.3K |
|
1925
ABM Industries
ABM
$2.8B
| – | – |
-11,914
| Closed | -$433K |
|
Similar funds
Wellington Management Group's Q4 2019 Portfolio in Review
As of Q4 2019, Wellington Management Group held 2,205 positions worth $477B, up 7.6% from $443B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Wellington Management Group's Q4 2019 filing shows 192 new, 703 increased, 960 reduced and 204 closed positions. Its largest new stake was Zoom: 2,196,622 shares worth $149M. The largest sale was Bristol-Myers Squibb, an estimated $1.5B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q4 2019 buy was Zoom: 2,196,622 shares worth $149M.
- Wellington Management Group added most to Apple in Q4 2019, an estimated $2.3B increase.
- Wellington Management Group's biggest Q4 2019 reduction was Bristol-Myers Squibb, cutting an estimated $1.5B.
- Wellington Management Group fully exited Genesee & Wyoming Inc. in Q4 2019, selling an estimated $365M.
- Wellington Management Group's ten largest holdings make up 16% of its $477B portfolio in Q4 2019.
- Wellington Management Group opened 192 new positions and closed 204 in Q4 2019.
- Wellington Management Group's portfolio value rose 7.6% quarter-over-quarter to $477B.
Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.